Siemens Healthcare Diagnostics is recalling approximately 1,307 units of Atellica CH and ADVIA Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP) reagents because they may produce biased quality control and patient test results. This issue affects specific lots of reagents used in diagnostic testing, which could lead to incorrect medical interpretations. Patients who have had urinary or cerebrospinal fluid protein tests performed using these specific lots should consult their healthcare provider, as the manufacturer is initiating a voluntary correction for these diagnostic tools.
The affected reagent lots may produce inaccurate test results that do not reflect the actual protein levels in a patient's sample. This bias could lead to misdiagnosis or incorrect treatment decisions based on flawed diagnostic data.
Manufacturer notification and correction regarding biased results.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.